Kufstein, Austria

Katja Vorndran

This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Ag. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katja Vorndran. Retrieved from https://idiyas.com/inventor/katja-vorndran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katja Vorndran: Innovator in Cefalosporin Synthesis

Introduction

Katja Vorndran is a notable inventor based in Kufstein, Austria. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of cephalosporins. Her innovative work has led to advancements in antibiotic production, which are crucial for medical applications.

Latest Patents

Katja Vorndran holds a patent for a process for the production of intermediates used in cefalosporin synthesis. This patent describes a method for producing intermediates with a specific formula that can be utilized in the synthesis of cephalosporins, such as cefepime. The process involves the desilyation of a compound with a silyl-protecting group, followed by a reaction with an organic base to obtain the desired compound.

Career Highlights

Vorndran is currently employed at Sandoz AG, a global leader in generic pharmaceuticals. Her work at Sandoz has allowed her to focus on innovative solutions in drug development. With her expertise, she has contributed to the advancement of antibiotic therapies, enhancing their efficacy and safety.

Collaborations

Throughout her career, Katja has collaborated with esteemed colleagues, including Johannes Ludescher and Hubert Sturm. These collaborations have fostered a productive environment for research and development, leading to significant breakthroughs in their field.

Conclusion

Katja Vorndran's contributions to cefalosporin synthesis exemplify her dedication to innovation in pharmaceutical chemistry. Her work not only advances scientific knowledge but also plays a vital role in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…